Nangiamakker P, Thompson E, Hogan C, Ochieng J, Raz A
WAYNE STATE UNIV,SCH MED,KARMANOS CANC INST,DETROIT,MI 48201. WAYNE STATE UNIV,SCH MED,DEPT PATHOL,DETROIT,MI 48201. WAYNE STATE UNIV,SCH MED,DEPT RADIAT ONCOL,DETROIT,MI 48201. GEORGETOWN UNIV,MED CTR,LOMBARDI CANC RES CTR,DEPT CELL BIOL,WASHINGTON,DC 20001. GEORGETOWN UNIV,MED CTR,LOMBARDI CANC RES CTR,DEPT ORTHOPED SURG,WASHINGTON,DC 20001. MEHARRY MED COLL,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37208.
Int J Oncol. 1995 Nov;7(5):1079-87. doi: 10.3892/ijo.7.5.1079.
The human galectin-3 is a galactoside-binding protein of 31 kDa which functions as a receptor for glycoproteins containing poly N-acetyllactosamine side chains and as a substrate for matrix metalloproteinases-2 and -9. We studied its expression by flow cytoflourimetry, Western, Northern and Southern analyses, in five cultured human breast carcinoma cell lines previously characterized as nontumorigenic, poorly metastatic or metastatic in nude mice. The expression of galectin-3 correlated with the reported tumorigenicity of the cells. The introduction of recombinant galectin-3 into the null expressing non-tumorigenic BT-549 cells resulted in the acquisition of anchorage-independent growth properties in all and tumorigenicity in 3/4 sense transfected cell clones. The data indicate a relationship between galectin-3 expression and malignancy of human breast carcinoma cell lines.
人半乳糖凝集素-3是一种31 kDa的半乳糖苷结合蛋白,它作为含有聚N-乙酰乳糖胺侧链的糖蛋白的受体,以及基质金属蛋白酶-2和-9的底物发挥作用。我们通过流式细胞术、蛋白质免疫印迹法、Northern印迹法和Southern印迹法,研究了其在五种培养的人乳腺癌细胞系中的表达情况,这些细胞系之前被鉴定为在裸鼠中无致瘤性、低转移性或转移性。半乳糖凝集素-3的表达与报道的细胞致瘤性相关。将重组半乳糖凝集素-3导入无表达的非致瘤性BT-549细胞中,导致所有细胞均获得了不依赖贴壁生长的特性,并且在3/4的正义转染细胞克隆中具有致瘤性。这些数据表明半乳糖凝集素-3的表达与人乳腺癌细胞系的恶性程度之间存在关联。